ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)
$15.44 1.1 (7.6709%)
Analysed ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) News Sources
Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?
03-07-2026
yahoo.com
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026
28-07-2026
yahoo.com
Arcturus Therapeutics Q2 Earnings Call Highlights
06-08-2026
marketbeat.com
Moderna And Merck's Cancer Vaccine: Are Investors Putting The Cart Before The Horse?
20-08-2026
yahoo.com
Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech’s Biggest Players
21-08-2026
yahoo.com
Arcturus Therapeutics Holdings Inc. Q1 2026 Earnings Call Summary
08-05-2026
moby.co
Arcturus Therapeutics Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies
05-06-2026
marketbeat.com
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
20-07-2026
yahoo.com
Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline
12-08-2026
marketbeat.com
What is the current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is $15.44.
ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is $1.1.
ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is 7.6709%.
What is the most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The most recent sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is .
SEC-8K** Filing Available For ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.